These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7653133)
21. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. Stevens DL; Tanner MH; Winship J; Swarts R; Ries KM; Schlievert PM; Kaplan E N Engl J Med; 1989 Jul; 321(1):1-7. PubMed ID: 2659990 [TBL] [Abstract][Full Text] [Related]
22. [Streptococcal respiratory infection in large organized children's collectives and experience in optimizing its prevention]. Obernikhin IM; Kolpakov SL; Vykhrestiuk AV; Iakovlev AA; Briko NI Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):57-63. PubMed ID: 8059574 [TBL] [Abstract][Full Text] [Related]
23. Tissue cages for study of experimental streptococcal infection in rabbits. III. Influence of immunization with erythrogenic toxin type A (ET A) and its toxoid on subsequent infection with an ET A producing strain. Knöll H; Holm SE; Gerlach D; Ozegowski JH; Köhler W Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):366-76. PubMed ID: 3064496 [TBL] [Abstract][Full Text] [Related]
27. [Epidemiology and pathogenesis of streptococcal infection]. Köhler W Immun Infekt; 1992 Jul; 20(3):92-8. PubMed ID: 1500078 [TBL] [Abstract][Full Text] [Related]
28. [Typing of group A streptococci isolated from urban population of different social status and age]. Riapis LA; Briko NI; Dmitrieva NF; Eshchina AS; Pronskiĭ AV; Filatov NN; Ivanenko AV; Salova NIa; Sizykh EV; Pavlovskiĭ SS; Skorkina IuA; Trofimov DIu; Kirillov MIu; Sobolev VI Zh Mikrobiol Epidemiol Immunobiol; 2007; (1):30-4. PubMed ID: 17523425 [TBL] [Abstract][Full Text] [Related]
29. [Induction of immune interferon by erythrogenic toxins A and B from Streptococcus pyogenes]. Tonew E; Gerlach D; Tonew M; Köhler W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):463-71. PubMed ID: 6817542 [TBL] [Abstract][Full Text] [Related]
30. Carriage of Streptococcus pyogenes among infants and toddlers attending day-care facilities in closed communities in southern Israel. Yagupsky P; Landau D; Beck A; Dagan R Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):54-8. PubMed ID: 7729455 [TBL] [Abstract][Full Text] [Related]
31. [Isolation and characterization of erythrogenic toxins. VII. Study of the erythrogenic toxin type C produced by Streptococcus pyogenes]. Ozegowski JH; Knöll H; Gerlach D; Köhler W Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):38-50. PubMed ID: 6431714 [TBL] [Abstract][Full Text] [Related]
32. Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012. Olafsdottir LB; Erlendsdóttir H; Melo-Cristino J; Weinberger DM; Ramirez M; Kristinsson KG; Gottfredsson M Euro Surveill; 2014 May; 19(17):5-14. PubMed ID: 24821122 [TBL] [Abstract][Full Text] [Related]
33. [The incidence of group A beta haemolytic streptococci in upper respiratory tract infections in Erzurum]. Enöz M; Sevinç I; Inançli HM Kulak Burun Bogaz Ihtis Derg; 2009; 19(6):285-8. PubMed ID: 20030595 [TBL] [Abstract][Full Text] [Related]
34. Tissue cages for study of experimental streptococcal infection in rabbits. I. Production of erythrogenic toxins in vivo. Knöll H; Holm SE; Gerlach D; Köhler W Immunobiology; 1982; 162(2):128-40. PubMed ID: 6811417 [TBL] [Abstract][Full Text] [Related]
35. The dynamics of streptococcal infections in a defined population of children: serotypes associated with skin and respiratory infections. Anthony BF; Kaplan EL; Wannamaker LW; Chapman SS Am J Epidemiol; 1976 Dec; 104(6):652-66. PubMed ID: 793381 [TBL] [Abstract][Full Text] [Related]
36. Group A streptococcus-associated upper respiratory tract infections in a day-care center. Smith TD; Wilkinson V; Kaplan EL Pediatrics; 1989 Mar; 83(3):380-4. PubMed ID: 2645567 [TBL] [Abstract][Full Text] [Related]
37. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates. Newton D; Norrby-Teglund A; McGeer A; Low DE; Schlievert PM; Kotb M Adv Exp Med Biol; 1997; 418():525-9. PubMed ID: 9331707 [No Abstract] [Full Text] [Related]
38. [Antistreptolysin O in subjects with incidence of group a Streptococci in the upper respiratory tract (author's transl)]. Stefanovic J; Kotulová D; Chudík J; Dvoranová R Bratisl Lek Listy; 1975 Dec; 64(6):685-91. PubMed ID: 1104084 [No Abstract] [Full Text] [Related]
39. [Streptococcal group A carriage: new data on the characteristics of the biology of the causative agent and of the immune response of the host]. Briko NI; Dmitrieva NF; Eshchina AS; Dynga LO; Shevelev BI; Sobolev VI; Vylegzhanina ES; Kuksiuk PP Zh Mikrobiol Epidemiol Immunobiol; 1994; Suppl 1():51-5. PubMed ID: 7856351 [TBL] [Abstract][Full Text] [Related]
40. [Properties of extracellular products produced by group A streptococci isolated from patients with streptococcal toxic shock syndrome]. Suzuki J; Matsubuchi S; Yoshihara E; Kobayashi S; Okamura K; Okuda T; Okazaki M; Furuya N; Uchimura H; Tokunaga T; Shimazaki S Kansenshogaku Zasshi; 1997 Dec; 71(12):1187-92. PubMed ID: 9483877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]